Article

OTC MEVACOR GETS THUMBS DOWN AGAIN-January 2008

Merck & Co Inc's third bid

Related Videos
Image credit: JJAVA | stock.adobe.com
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Pharmacist and patient in a community pharmacy -- Image credit: Gorodenkoff | stock.adobe.com
X-ray image of human brain with neurons -- Image credit: Who is Danny | stock.adobe.com
Related Content
Respiratory Syncytial Virus (RSV) life-threatening disease prevention and protection antibodie immunity vaccination or injection concept. Syringe near RSV vaccine word or text - Image credit: ECO LENS | stock.adobe.com
April 17th 2025

ACIP Votes to Expand Lowering RSV Vaccine Recommendation Age to 50 for High-Risk Adults

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Woman holding breathing inhaler, nebulizer, in hand preparing for home procedure, treatment of cold in sick season
April 16th 2025

Inhaled siRNA-Based MIR 19 Reduces Progression to Severe Disease in Outpatients With Mild COVID-19

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
The Tech Truth: Stepping Up as Pharmacy Technician Leaders
April 16th 2025

The Tech Truth: Stepping Up as Pharmacy Technician Leaders

Caitlin Quigley, CPhT
Man with heavy headache - 3D illustration - Image credit: peterschreiber.media | stock.adobe.com
April 16th 2025

Diazepam Nasal Spray Receives FDA Approval for Seizure Clusters in Individuals 2 Years and Older

Kennedy Ferruggia, Assistant Editor